CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Single-arm, Phase II Study to Evaluate Safety and Efficacy of Doxorubicin in Combination With Radiotherapy, Temozolomide and Valproic Acid in Patients With Glioblastoma Multiforme (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02758366
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:49.536717+00:00
Published At: 2021-02-09T00:00:00+00:00
Record Updated At: 2021-02-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Glioblastoma (GBM)", "DIPG", "Brainstem Glioma, Pediatric", "Diffuse Spinal Glioma", "Bilateral Thalamic Glioma", "Gliomatosis Cerebri", "Anaplastic Astrocytoma", "Midline Diffuse Glioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-09"
protocolSection.identificationModule.nctId: "NCT02758366"
protocolSection.identificationModule.officialTitle: "An Open-label, Single-arm, Phase II Study to Evaluate Safety and Efficacy of Doxorubicin in Combination With Radiotherapy, Temozolomide and Valproic Acid in Patients With Glioblastoma Multiforme (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.